Patient info

Medomon XL 60 mg prolonged-release tablets – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
Pharmacy medicine (P)
Medicine strength:
60 mg
Contains active substance:

Patient leaflet - Medomon XL 60 mg prolonged-release tablets

1. What Medomon XL Tablets are and what are they used for

Medomon XL Tablets contains a medicine called isosorbide mononitrate. This belongs to a group of medicines called ‘nitrates’.

  • It is used to prevent chest pain (angina).
  • It works by making the blood vessels relax and widen. This makes it easier for the heart

    to pump blood around the body.

2. Before you take Medomon XL Tablets

Do not take Medomon XL Tablets if you:

  • are allergic (hypersensitive) to isosorbide mono nitrate or any of the other ingredients in

    the tablets (see Section 6 and end of Section 2).

  • suffer from a condition called constrictive pericarditis (inflammation of the lining around

    the heart), or cardiac tamponade (where the fluid around the heart puts pressure on the heart).

  • are having a heart attack (acute myocardial infarction)
  • suffer from very low blood pressure (hypotension)
  • suffer from a condition called aortic stenosis (narrowing of the main artery coming from

    the heart).

  • suffer from a condition called mitral stenosis (narrowing of the mitral valve on the left

    side of the heart)

  • suffer from a condition called hypertrophic cardiomyopathy (a heart disease which

    causes the heart muscle to become thick and can cause symptoms such as chest pain, dizziness and collapse).

  • suffer from a condition which can increase the pressure on the brain e.g. a recent

    serious head injury and bleeding into the brain (cerebral haemorrhage)

  • suffer from severe anaemia (reduction in the number of red blood cells)
  • suffer from closed angle glaucoma (a condition which can causes sudden attacks of

    eye pain due to rapid increases in eye pressure, with symptoms such as blurred vision, painful red eye and headache)

  • are taking any medicines for erectile problems, such as Viagra (Sildenafil), which

    belong to a group of medicines called phosphodiesterase type 5 inhibitors (see section on Interaction with other medicines).

    • are in the first three months of pregnancy

Do not take Medomon XL Tablets if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking Medomon XL Tablets.

Warnings and precautions

Talk to your doctor or pharmacist before taking Medomon XL Tablets if you:

  • have had any serious damage to your heart, such as a heart attack or operation
  • suffer from liver or kidney disease
  • suffer from hypothyroidism (underactive thyroid gland)
  • suffer from hypothermia (very low body temperature)
  • suffer from malnutrition (severe lack of food)
  • drink alcohol - alcohol should be avoided during treatment with Medomon XL Tablets If any of the above apply to you, or you are not sure, talk to your doctor or pharmacist before taking Medomon XL Tablets.

Reminder

This medicine should not be used to treat a sudden angina attack. Your doctor should prescribe (GTN) glyceryl trinitrate (tablets or spray) if you have a sudden angina attack. Medomon XL Tablets is used to prevent attacks of angina, and should be used regularly, as prescribed by the doctor.

other medicines

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines that you buy without a prescription and herbal medi-cines. This is because Medomon XL Tablets can affect the way some medicines work and some medicines can have an effect on Medomon XL Tablets.

Do not take Medomon XL Tablets if you are taking the following medicines:

  • medicines which reduce blood pressure such as:

o ACE inhibitors, e.g. enalapril, captopril

o beta-blockers, e.g. atenolol, propranolol

o calcium channel blockers, e.g. diltiazem, verapamil, nifedipine

o angiotensin II receptor antagonists, e.g. candesartan

o phosphodiesterase Type 5 Inhibitors e.g. sildenafil

o alprostadil used to treat erectile dysfunction

o aldesleukin used to treat kidney cancer and melanoma

  • benzodiazepines, e.g. temazepam
  • tricyclic antidepressants, e.g. amitriptyline.

Pregnancy and breast-feeding

Ask your doctor for advice before taking Medomon XL Tablets if you are pregnant, planning to become pregnant or are breast-feeding.

Driving and using machines

You may experience dizziness when you start taking Medomon XL Tablets. You should therefore know how you react to Medomon XL Tablets before you drive or use machines.

Important information about some of the ingredients of Medomon XL Tablets

These tablets contain lactose. Consult your doctor if you have been told you have an intolerance to some sugars before taking these tablets.

Manufacturer:

Rudipharm Limited

Oak House, Reeds Crescent, Watford, WD24 4QP, UK

To listen to or request a copy of this leaflet in Braille, large print or audio please call, +44 (0) 1293 827819 (UK only) Please be ready to give the following information: Product name: Reference number: Medomon XL 60mg PL 49565/0025

Prolonged Release Tablets

This leaflet was last revised in March 2026.

Marketing Authorisation Holder:

Rudipharm Limited

Unit 6, Salbrook Road Industrial Estate

Salbrook Road, Redhill, Surrey RH1 5GJ, UK

3. How to take Medomon XL Tablets

Always take Medomon XL Tablets exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.

  • Swallow the tablets whole or broken in half (if this is easier to swallow).
  • Take the tablets with half a glass of water
  • Do not crush or chew the tablet

Dosage:

Adults: One tablet to be taken once daily in the morning. This may be increased to two tablets on the advice of your doctor, in which case both tablets should be taken once daily in the morning.

Treatment is sometimes started for the first 2-4 days, with half a tablet once daily in the morning in order to minimise the possibility of headache.

Elderly: The usual dose is the same as the adult dose.

Children:

Not recommended for use in children.

You must not take Medomon XL Tablets for a sudden attack of angina. If you have a sudden attack, take a glyceryl trinitrate tablet (follow the instructions given on the label). Very occasionally, some people see the remains of the tablet in their bowel motions. This is quite normal and does not mean that the medicine has not been released.

If you take more Medomon XL Tablets than you should

If you (or someone else) swallow a lot of tablets at the same time, or you think a child has swallowed any of these tablets, contact your nearest hospital casualty department or your doctor immediately. Take this leaflet and your tablets with you. The symptoms of an overdose may be pulsing headache, reddening of the skin, cold perspiration, nausea, vomiting and a fast heartbeat.

If you forget to take Medomon XL Tablets

If you forget to take your tablet(s) but remember within 12 hours of the usual time, take it when you remember. If you remember more than 12 hours after your usual time, don't take the tablet and just carry on with the next dose when it is due.

If you stop taking Medomon XL Tablets

Do not stop taking your tablets without first discussing this with your doctor as this may be harmful.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, Medomon XL Tablets can cause side effects, although not everybody gets them.

The following side effects may happen with this medicine:

  • Headache
  • Feeling sick (nausea)
  • Feeling dizzy

The above problem usually disappears with time.

Other possible side effects:

Common (may affect up to 1 in 10 people)

  • Low blood pressure (this may make you feel faint or dizzy)
  • Faster heartbeat (tachycardia)
  • Headache

    • Feeling dizzy
    • Feeling sick (nausea)

Uncommon (may affect up to 1 in 100 people)

  • Being sick (vomiting)
  • Diarrhoea

Rare (may affect up to 1 in 1,000 people)

  • Fainting
  • Rash
  • Itchy skin

Very rare (may affect up to 1 in 10,000 people)

  • Pain in muscles

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacists. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow card Scheme: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side affects you can help provide more information on the safety of this medicine.

5. How to store Medomon XL Tablets

Keep out of the reach and sight of children.

Store your tablets in the original package.

Do not store above 25°C

Do not use your medicine after the expiry date shown on the label.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

6. Further information What Medomon XL Tablets contain

Each tablet contains 60mg of the active ingredient isosorbide -5-mononitrate. The other substances are lactose monohydrate, hypromellose, maize starch, glyceryl palmitostearate and magnesium stearate.

What Medomon XL Tablets looks like and contents of the pack

The tablets are white, capsule shaped, biconvex and uncoated with scoring. They are supplied in cartons containing two strips of blister packs - each strip containing 14 tablets (28 tablets per carton).

Medomon XL Tablets - 60 mg

Headings: 12pt (Bold)

Sub-Heading: 9pt (Bold)

Normal Text: 9pt (Regular)

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 49565/0025

Last revision stated in the text: March 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Medomon XL 60 mg prolonged-release tablets

Prescription needed? No, but it is sold only in pharmacies (P)
Active substance Isosorbide mononitrate
Strength 60 mg
Pharmaceutical form Modified-release tablet
Prolonged release tablets
How is it taken Oral
Excipients Lactose monohydrate,, hypromellose,, maize starch,, glyceryl palmitostearate, magnesium stearate
Pack sizes 28 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 36 months
Storage Do not store above 25°C. Store in original container.
Drug group (ATC)
  1. C Cardiovascular system drugs
    1. C01 Cardiac therapy drugs
      1. C01D Vasodilators used in cardiac diseases
        1. C01DA Organic nitrates used in cardiac disease
          1. C01DA14 isosorbide mononitrate
Marketing authorisation PL 49565/0025 (first authorised 18 April 2012)
Marketing authorisation holder Rudipharm Limited
Codes GTIN 5060705240175 · BNF 02060100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.